There has been increasing evidence that chronic immune activation plays critical roles in the pathogenesis of DCM. CD4(+) LAP(+) Tregs are a newly identified T cell subset with suppressive function on the immune response. This study was designed to investigate whether the circulating frequency and function of CD4(+)LAP(+) Tregs would be impaired in patients with DCM. The results demonstrated that DCM patients had a significantly lower frequency of circulating CD4(+)LAP(+) Tregs compared with control donors. CD4(+)LAP(+) Tregs from DCM patients showed compromised function to suppress proliferation of CD4(+) LAP(-)CD25(int/low) T cells and proliferation and IgG production of B cells. Moreover, B cell proliferation and IgG subset production could be directly suppressed by CD4(+) LAP(+) Tregs. TGF-β and contact-dependent mechanisms were involved in CD4(+)LAP(+) Treg-mediated suppression. Correlation analysis suggested that CD4(+)LAP(+) Treg frequency was positively correlated with LVEF and negatively correlated with serum IgG3 and NT-proBNP concentration in patients with DCM. Our results are the first to demonstrate that the frequencies of CD4(+)LAP(+) Tregs in patients with DCM are reduced and that their suppressive function is compromised. Defective CD4(+) LAP(+) Tregs may be an underlying mechanism of immune activation in DCM patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1189/jlb.5A1014-469RR | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Latency-associated peptide (LAP)CD4 regulatory T cells prevent atherosclerosis by modulating macrophage polarization.
Clin Immunol
October 2023
Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China; Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China. Electronic address:
Rationale: A persistent autoimmune and inflammatory response plays a critical role in the progression of atherosclerosis. The transcription factor forkhead box P3 (Foxp3)CD4 regulatory T cells (Foxp3 Tregs) attenuate atherosclerosis. Latency-associated peptide (LAP)CD4 T cells are a new class of Tregs whose role in atherosclerosis is unknown.
View Article and Find Full Text PDFSuppression of anti-drug antibody formation against coagulation factor VIII by oral delivery of anti-CD3 monoclonal antibody in hemophilia A mice.
Cell Immunol
March 2023
Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address:
Article Synopsis
- - The study investigated the use of oral anti-CD3 monoclonal antibodies to prevent the formation of anti-drug antibodies (ADAs) in hemophilia A mice undergoing clotting factor VIII (FVIII) protein replacement therapy.
- - Administering low-dose oral anti-CD3 F(ab') led to a reduction in neutralizing ADAs, especially when given at the same time as FVIII therapy, with immune tolerance linked to certain populations of CD4 T cells.
- - Combining oral anti-CD3 treatment with oral FVIII antigen intake did not enhance the suppression of ADAs, indicating that while oral anti-CD3 shows promise, its mechanisms of action are different and not synergistic with the FVIII antigen approach.
Myocardial Milieu Favors Local Differentiation of Regulatory T Cells.
Circ Res
March 2023
Department of Internal Medicine I (M.D., E.W., D.E.A., L.R., L.P., U.H., S.F., G.C.R.), University Hospital Würzburg, Germany.
Background: In the past years, several studies investigated how distinct immune cell subsets affects post-myocardial infarction repair. However, whether and how the tissue environment controls these local immune responses has remained poorly understood. We sought to investigate how antigen-specific T-helper cells differentiate under myocardial milieu's influence.
View Article and Find Full Text PDFNasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjects.
Front Immunol
December 2022
Harvard Medical School, Boston, MA, United States.
Background: Parenteral anti-CD3 Mab (OKT3) has been used to treat transplant rejection and parental administration of a humanized anti-CD3 Mab (Teplizumab) showed positive effects in diabetes. Nasal administration of anti-CD3 Mab has not been carried out in humans. Nasal anti-CD3 Mab suppresses autoimmune diseases and central nervous system (CNS) inflammation in animal models.
View Article and Find Full Text PDFFoxP3 CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation.
Front Immunol
August 2022
Department of Biological Sciences and CERMO-FC Research Centre, Université du Québec à Montréal (UQAM), Montreal, QC, Canada.
Objectives: Besides CD4 regulatory T-cells (Tregs), immunosuppressor FoxP3 CD8 T-cells are emerging as an important subset of Tregs, which contribute to immune dysfunction and disease progression in HIV infection. However, FoxP3 CD8 T-cell dynamics in acute HIV infection and following early antiretroviral therapy (ART) initiation remain understudied.
Methods: Subsets of FoxP3 CD8 T-cells were characterized both prospectively and cross-sectionally in PBMCs from untreated acute (n=26) and chronic (n=10) HIV-infected individuals, early ART-treated in acute infection (n=10, median of ART initiation: 5.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!